chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria, Vaccination site pain
Clinical narrative: Itching all over her body after the 2nd dose; Hives all over her body after the 2nd dose; Injection site soreness after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over her body after the 2nd dose), URTICARIA (Hives all over her body after the 2nd dose) and VACCINATION SITE PAIN (Injection site soreness after the 2nd dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE, CHLORTHALIDONE and CLONIDINE for an unknown indication.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Injection site soreness after the 2nd dose). On 16-May-2021, the patient experienced PRURITUS (Itching all over her body after the 2nd dose) and URTICARIA (Hives all over her body after the 2nd dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 16-May-2021, VACCINATION SITE PAIN (Injection site soreness after the 2nd dose) had resolved. At the time of the report, PRURITUS (Itching all over her body after the 2nd dose) and URTICARIA (Hives all over her body after the 2nd dose) outcome was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: had a muscle pain in legs; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (had a muscle pain in legs) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Blood pressure high and Back disorder NOS (back problem). Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ) for Blood pressure high, TRAMADOL for Pain, VITAMINS NOS, OMEPRAZOLE and MONTELUKAST for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced MYALGIA (had a muscle pain in legs). At the time of the report, MYALGIA (had a muscle pain in legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was also taking concomitant drug Mesaconic acid (2 tablets a day) for an unknown indication. It was reported that no treatment was taken for the events.
Sex: F
Vaccine: COVID19
Symptoms: Incomplete course of vaccination, Malaise, Urine abnormality
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of malaise (not feeling well), urine abnormality (can't hold urine) and incomplete course of vaccination (supposed to take second shot of Moderna COVID-19 vaccine today) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 16, 2021, patient experienced malaise (not feeling well) and urine abnormality (can't hold urine). On an unknown date, patient experienced incomplete course of vaccination (supposed to take second shot of Moderna COVID-19 vaccine today). At the time of the report, malaise (not feeling well) and urine abnormality (can't hold urine) outcome: unknown; and incomplete course of vaccination (supposed to take second shot of Moderna COVID-19 vaccine today) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Chills, Pyrexia, Vomiting
Clinical narrative: Stomach Pain; worse reaction with terrible chills; Temp of 102 degrees; Vomiting; Bad pain in hip; Pain in left knee; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach Pain), CHILLS (worse reaction with terrible chills), PYREXIA (Temp of 102 degrees), VOMITING (Vomiting) and ARTHRALGIA (Bad pain in hip) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Stomach Pain), CHILLS (worse reaction with terrible chills), PYREXIA (Temp of 102 degrees), VOMITING (Vomiting), ARTHRALGIA (Bad pain in hip) and ARTHRALGIA (Pain in left knee). At the time of the report, ABDOMINAL PAIN UPPER (Stomach Pain), CHILLS (worse reaction with terrible chills), PYREXIA (Temp of 102 degrees) and VOMITING (Vomiting) outcome was unknown, ARTHRALGIA (Bad pain in hip) had resolved and ARTHRALGIA (Pain in left knee) had not resolved.            No treatment information was provided.  No concomitant medication was provided.   This case was linked to MOD-2021-019517, MOD-2021-019517 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (FEVER) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. No medical history was reported. Concomitant products included FISH OIL for an unknown indication. On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, the patient experienced PYREXIA (FEVER). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PYREXIA (FEVER) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body pain), PYREXIA (high fever), HEADACHE (head hurts bad) and CHILLS (chills) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination. No Medical History was Reported. On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced MYALGIA (body pain), PYREXIA (high fever), HEADACHE (head hurts bad) and CHILLS (chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 4 dosage form and PARACETAMOL (TYLENOL) at a dose of 11 dosage form. At the time of the report, MYALGIA (body pain), PYREXIA (high fever), HEADACHE (head hurts bad) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: A little bit of sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little bit of sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (A little bit of sore arm). At the time of the report, PAIN IN EXTREMITY (A little bit of sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-133096, MOD-2021-133200 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: There may have been temperature excursion and vaccines were administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (There may have been temperature excursion and vaccines were administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (There may have been temperature excursion and vaccines were administered). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (There may have been temperature excursion and vaccines were administered) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   The reporting physician mentioned that both 1st and 2nd doses of Moderna COVID-19 vaccine were administered to about 120 patients (estimated number) from several different vials that may have suffered temperature excursion over several different days.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow-up document received on 15-Jun-2021 does not contain any significant information. The reporter provided additional email address.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Bone pain, Chills, Decreased appetite
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (don't want to eat, not quite nauseas / not have a lot of appetite), DIZZINESS (light headed), BONE PAIN (Horrible bones and muscle pains), ASTHENIA (felt really weak/feels weak/no energy and kind of weak) and CHILLS (horrible chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Depression and Insomnia. Concurrent medical conditions included Osteoporosis. Concomitant products included TRAZODONE from 15-Jan-2021 to an unknown date for Anxiety, MARIHUANA for Depression, DENOSUMAB (PROLIA), VITAMIN D [VITAMIN D NOS] and CALCIUM for Osteoporosis, MAGNESIUM for Restless leg syndrome, PROBIOTICS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication. On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced DECREASED APPETITE (don't want to eat, not quite nauseas / not have a lot of appetite), BONE PAIN (Horrible bones and muscle pains), CHILLS (horrible chills), PYREXIA (99.4°F fever), MYALGIA (Horrible bones and muscle pains) and NAUSEA (extreme nausea). On 12-May-2021, the patient experienced DIZZINESS (light headed), ASTHENIA (felt really weak/feels weak/no energy and kind of weak), VOMITING (made herself vomit) and FATIGUE (fatigue). The patient was treated with FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 12-May-2021, BONE PAIN (Horrible bones and muscle pains), ASTHENIA (felt really weak/feels weak/no energy and kind of weak), CHILLS (horrible chills), PYREXIA (99.4°F fever), MYALGIA (Horrible bones and muscle pains), NAUSEA (extreme nausea) and VOMITING (made herself vomit) had resolved. At the time of the report, DECREASED APPETITE (don't want to eat, not quite nauseas / not have a lot of appetite), DIZZINESS (light headed) and FATIGUE (fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2021, Body temperature: 99.4°f 99.4°F. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient administers Migraine Medication as treatment. This case was linked to MOD-2021-133265. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up document received on 06-Jul-2021, concomitant medication updated.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (don't want to eat, not quite nauseas / not have a lot of appetite), DIZZINESS (light headed), BONE PAIN (Horrible bones and muscle pains), ASTHENIA (felt really weak/feels weak/no energy and kind of weak) and CHILLS (horrible chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Depression and Insomnia. Concurrent medical conditions included Osteoporosis. Concomitant products included TRAZODONE from 15-Jan-2021 to an unknown date for Anxiety, MARIHUANA for Depression, DENOSUMAB (PROLIA), VITAMIN D [VITAMIN D NOS] and CALCIUM for Osteoporosis, MAGNESIUM for Restless leg syndrome, PROBIOTICS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication. On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced DECREASED APPETITE (don't want to eat, not quite nauseas / not have a lot of appetite), BONE PAIN (Horrible bones and muscle pains), CHILLS (horrible chills), PYREXIA (99.4°F fever), MYALGIA (Horrible bones and muscle pains) and NAUSEA (extreme nausea). On 12-May-2021, the patient experienced DIZZINESS (light headed), ASTHENIA (felt really weak/feels weak/no energy and kind of weak), VOMITING (made herself vomit) and FATIGUE (fatigue). The patient was treated with FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 12-May-2021, BONE PAIN (Horrible bones and muscle pains), ASTHENIA (felt really weak/feels weak/no energy and kind of weak), CHILLS (horrible chills), PYREXIA (99.4°F fever), MYALGIA (Horrible bones and muscle pains), NAUSEA (extreme nausea) and VOMITING (made herself vomit) had resolved. At the time of the report, DECREASED APPETITE (don't want to eat, not quite nauseas / not have a lot of appetite), DIZZINESS (light headed) and FATIGUE (fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2021, Body temperature: 99.4°f 99.4°F. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient administers Migraine Medication as treatment. This case was linked to MOD-2021-133265. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up document received on 06-Jul-2021, concomitant medication updated.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (don't want to eat, not quite nauseas / not have a lot of appetite), DIZZINESS (light headed), BONE PAIN (Horrible bones and muscle pains), ASTHENIA (felt really weak/feels weak/no energy and kind of weak) and CHILLS (horrible chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Depression and Insomnia. Concurrent medical conditions included Osteoporosis. Concomitant products included TRAZODONE from 15-Jan-2021 to an unknown date for Anxiety, MARIHUANA for Depression, DENOSUMAB (PROLIA), VITAMIN D [VITAMIN D NOS] and CALCIUM for Osteoporosis, MAGNESIUM for Restless leg syndrome, PROBIOTICS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication. On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced DECREASED APPETITE (don't want to eat, not quite nauseas / not have a lot of appetite), BONE PAIN (Horrible bones and muscle pains), CHILLS (horrible chills), PYREXIA (99.4°F fever), MYALGIA (Horrible bones and muscle pains) and NAUSEA (extreme nausea). On 12-May-2021, the patient experienced DIZZINESS (light headed), ASTHENIA (felt really weak/feels weak/no energy and kind of weak), VOMITING (made herself vomit) and FATIGUE (fatigue). The patient was treated with FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 12-May-2021, BONE PAIN (Horrible bones and muscle pains), ASTHENIA (felt really weak/feels weak/no energy and kind of weak), CHILLS (horrible chills), PYREXIA (99.4°F fever), MYALGIA (Horrible bones and muscle pains), NAUSEA (extreme nausea) and VOMITING (made herself vomit) had resolved. At the time of the report, DECREASED APPETITE (don't want to eat, not quite nauseas / not have a lot of appetite), DIZZINESS (light headed) and FATIGUE (fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2021, Body temperature: 99.4°f 99.4°F. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient administers Migraine Medication as treatment. This case was linked to MOD-2021-133265. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up document received on 06-Jul-2021, concomitant medication updated.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Myalgia
Clinical narrative: Sore arm; Received first dose from a vial that's been punctured for more than 30hours.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received first dose from a vial that's been punctured for more than 30hours.) and MYALGIA (Sore arm) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received first dose from a vial that's been punctured for more than 30hours.). On an unknown date, the patient experienced MYALGIA (Sore arm). On 13-May-2021, EXPIRED PRODUCT ADMINISTERED (Received first dose from a vial that's been punctured for more than 30hours.) had resolved. At the time of the report, MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported    This case was linked to US-MODERNATX, INC.-MOD-2021-132835 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-132835:First patient case
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Peripheral swelling, Pyrexia
Clinical narrative: mild headech; developed swollen arm; developed fever; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 14-May-2021. The most recent information was received on 19-Jul-2021 and was forwarded to Moderna on 19-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (developed swollen arm), PYREXIA (developed fever) and HEADACHE (mild headech) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2021, the patient experienced PERIPHERAL SWELLING (developed swollen arm) and PYREXIA (developed fever). On an unknown date, the patient experienced HEADACHE (mild headech). At the time of the report, PERIPHERAL SWELLING (developed swollen arm), PYREXIA (developed fever) and HEADACHE (mild headech) outcome was unknown.            No concomitant medications were reported.  No treatment information was reported   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up information received on 19-JUL-2021 contains significant information.New event headache added
Sex: U
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: my tummy was upset nowhere near the severity of the first one; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (my tummy was upset nowhere near the severity of the first one) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (my tummy was upset nowhere near the severity of the first one). At the time of the report, ABDOMINAL DISCOMFORT (my tummy was upset nowhere near the severity of the first one) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-133883 (Patient Link).
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Fatigue, Headache, Heavy menstrual bleeding, Influenza like illness
Clinical narrative: "crazy,crazy" heavy period and has been bleeding for about a week and a half now; The next day she was on bed all day; Headache; Achiness; Felt tired; Felt like she had kind of like a flu; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING ("crazy,crazy" heavy period and has been bleeding for about a week and a half now), INFLUENZA LIKE ILLNESS (Felt like she had kind of like a flu), BEDRIDDEN (The next day she was on bed all day), MYALGIA (Achiness) and FATIGUE (Felt tired) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Perimenopause (usually period is pretty light). Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) and ALOE VERA, GLYCYRRHIZA GLABRA, RHEUM OFFICINALE POWDER, SENNA ALEXANDRINA (VENAX) for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like she had kind of like a flu), MYALGIA (Achiness) and FATIGUE (Felt tired). On 25-Apr-2021, the patient experienced BEDRIDDEN (The next day she was on bed all day) and HEADACHE (Headache). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING ("crazy,crazy" heavy period and has been bleeding for about a week and a half now). The patient was treated with PARACETAMOL (TYLENOL) on 25-Apr-2021 for Headache, at a dose of 1 dosage form. At the time of the report, HEAVY MENSTRUAL BLEEDING ("crazy,crazy" heavy period and has been bleeding for about a week and a half now), INFLUENZA LIKE ILLNESS (Felt like she had kind of like a flu), BEDRIDDEN (The next day she was on bed all day), MYALGIA (Achiness), FATIGUE (Felt tired) and HEADACHE (Headache) outcome was unknown.            Patient started with   flu, achiness, felt tired and she also had a headache    This case was linked to MOD-2021-133649 (Patient Link).
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: "crazy,crazy" heavy period and has been bleeding for about a week and a half now; The next day she was on bed all day; Headache; Achiness; Felt tired; Felt like she had kind of like a flu; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING ("crazy,crazy" heavy period and has been bleeding for about a week and a half now), INFLUENZA LIKE ILLNESS (Felt like she had kind of like a flu), BEDRIDDEN (The next day she was on bed all day), MYALGIA (Achiness) and FATIGUE (Felt tired) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Perimenopause (usually period is pretty light). Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) and ALOE VERA, GLYCYRRHIZA GLABRA, RHEUM OFFICINALE POWDER, SENNA ALEXANDRINA (VENAX) for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like she had kind of like a flu), MYALGIA (Achiness) and FATIGUE (Felt tired). On 25-Apr-2021, the patient experienced BEDRIDDEN (The next day she was on bed all day) and HEADACHE (Headache). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING ("crazy,crazy" heavy period and has been bleeding for about a week and a half now). The patient was treated with PARACETAMOL (TYLENOL) on 25-Apr-2021 for Headache, at a dose of 1 dosage form. At the time of the report, HEAVY MENSTRUAL BLEEDING ("crazy,crazy" heavy period and has been bleeding for about a week and a half now), INFLUENZA LIKE ILLNESS (Felt like she had kind of like a flu), BEDRIDDEN (The next day she was on bed all day), MYALGIA (Achiness), FATIGUE (Felt tired) and HEADACHE (Headache) outcome was unknown.            Patient started with   flu, achiness, felt tired and she also had a headache    This case was linked to MOD-2021-133649 (Patient Link).
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Rash, Vaccination site pain, Vaccination site warmth
Clinical narrative: two days ago the soreness around the shot area came back; red around the top of the arm; there is a rash; first day she had sore arm and it was warm around the area but then went away/kind of feels warm; first day she had sore arm and it was warm around the area but then went away; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (first day she had sore arm and it was warm around the area but then went away), VACCINATION SITE PAIN (two days ago the soreness around the shot area came back), ERYTHEMA (red around the top of the arm), RASH (there is a rash) and VACCINATION SITE WARMTH (first day she had sore arm and it was warm around the area but then went away/kind of feels warm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced PAIN IN EXTREMITY (first day she had sore arm and it was warm around the area but then went away). On 12-May-2021, the patient experienced VACCINATION SITE PAIN (two days ago the soreness around the shot area came back), ERYTHEMA (red around the top of the arm), RASH (there is a rash) and VACCINATION SITE WARMTH (first day she had sore arm and it was warm around the area but then went away/kind of feels warm). On 05-May-2021, PAIN IN EXTREMITY (first day she had sore arm and it was warm around the area but then went away) had resolved. At the time of the report, VACCINATION SITE PAIN (two days ago the soreness around the shot area came back), ERYTHEMA (red around the top of the arm), RASH (there is a rash) and VACCINATION SITE WARMTH (first day she had sore arm and it was warm around the area but then went away/kind of feels warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that she used wrap around the injection site. No concomitant medications were not provided.  Treatment medications were not provided.     This case was linked to US-MODERNATX, INC.-MOD-2021-134516 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-134516:Husband case
Sex: F
Vaccine: COVID19
Symptoms: Product storage error, Vaccination error
Clinical narrative: Room temperature vaccine administered to patient; Moderna Covid 19 vaccine left out at room temperature over 12 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Moderna Covid 19 vaccine left out at room temperature over 12 hours) and VACCINATION ERROR (Room temperature vaccine administered to patient) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid 19 vaccine left out at room temperature over 12 hours). On an unknown date, the patient experienced VACCINATION ERROR (Room temperature vaccine administered to patient). On 15-May-2021, PRODUCT STORAGE ERROR (Moderna Covid 19 vaccine left out at room temperature over 12 hours) had resolved. At the time of the report, VACCINATION ERROR (Room temperature vaccine administered to patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Dizziness, Feeling abnormal, Feeling jittery, Hyperglycaemia
Clinical narrative: Seeing dots in my vision.; high blood sugar; Dizzy; Felt jittery; felt weird; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEELING JITTERY (Felt jittery), FEELING ABNORMAL (felt weird), VISUAL IMPAIRMENT (Seeing dots in my vision.) and HYPERGLYCAEMIA (high blood sugar) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN and ERTUGLIFLOZIN PIDOLATE (STEGLATRO) for an unknown indication.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced DIZZINESS (Dizzy), FEELING JITTERY (Felt jittery) and FEELING ABNORMAL (felt weird). On 07-May-2021, the patient experienced HYPERGLYCAEMIA (high blood sugar). On 15-May-2021, the patient experienced VISUAL IMPAIRMENT (Seeing dots in my vision.). On 14-May-2021, HYPERGLYCAEMIA (high blood sugar) had resolved. At the time of the report, DIZZINESS (Dizzy), FEELING JITTERY (Felt jittery), FEELING ABNORMAL (felt weird) and VISUAL IMPAIRMENT (Seeing dots in my vision.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-May-2021, Blood glucose: 178 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: Seeing dots in my vision.; high blood sugar; Dizzy; Felt jittery; felt weird; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEELING JITTERY (Felt jittery), FEELING ABNORMAL (felt weird), VISUAL IMPAIRMENT (Seeing dots in my vision.) and HYPERGLYCAEMIA (high blood sugar) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN and ERTUGLIFLOZIN PIDOLATE (STEGLATRO) for an unknown indication.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced DIZZINESS (Dizzy), FEELING JITTERY (Felt jittery) and FEELING ABNORMAL (felt weird). On 07-May-2021, the patient experienced HYPERGLYCAEMIA (high blood sugar). On 15-May-2021, the patient experienced VISUAL IMPAIRMENT (Seeing dots in my vision.). On 14-May-2021, HYPERGLYCAEMIA (high blood sugar) had resolved. At the time of the report, DIZZINESS (Dizzy), FEELING JITTERY (Felt jittery), FEELING ABNORMAL (felt weird) and VISUAL IMPAIRMENT (Seeing dots in my vision.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-May-2021, Blood glucose: 178 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: NOT SLEEPING DEEPLY; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (NOT SLEEPING DEEPLY) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SLEEP DISORDER (NOT SLEEPING DEEPLY). At the time of the report, SLEEP DISORDER (NOT SLEEPING DEEPLY) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided  No relevant concomitant medications were reported
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hair colour changes
Clinical narrative: Shading of her hair after her second dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HAIR COLOUR CHANGES (Shading of her hair after her second dose of vaccine) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced HAIR COLOUR CHANGES (Shading of her hair after her second dose of vaccine). At the time of the report, HAIR COLOUR CHANGES (Shading of her hair after her second dose of vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: started feeling soreness on the second day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (started feeling soreness on the second day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (started feeling soreness on the second day). At the time of the report, PAIN (started feeling soreness on the second day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported   This case was linked to US-MODERNATX, INC.-MOD-2021-134044 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-134044:wife's case
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Feeling abnormal, Product dose omission issue, Somnolence
Clinical narrative: skip the 2nd dose and consequently did not receive it; 2 weeks later started to have different feeling; no energy; out of breath; sleepy during daytime; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (2 weeks later started to have different feeling), ASTHENIA (no energy), DYSPNOEA (out of breath), SOMNOLENCE (sleepy during daytime) and PRODUCT DOSE OMISSION ISSUE (skip the 2nd dose and consequently did not receive it) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN and FISH OIL (OMEGA 3 [FISH OIL]) for Cholesterol, HYDROCODONE for Pain, VITAMIN D NOS for Vitamin D deficiency.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced FEELING ABNORMAL (2 weeks later started to have different feeling), ASTHENIA (no energy), DYSPNOEA (out of breath) and SOMNOLENCE (sleepy during daytime). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (skip the 2nd dose and consequently did not receive it). At the time of the report, FEELING ABNORMAL (2 weeks later started to have different feeling), ASTHENIA (no energy), DYSPNOEA (out of breath) and SOMNOLENCE (sleepy during daytime) had not resolved and PRODUCT DOSE OMISSION ISSUE (skip the 2nd dose and consequently did not receive it) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: soft pain; This spontaneous case was reported by a physician and describes the occurrence of PAIN (soft pain) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Hypercholesterolemia.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN (soft pain). At the time of the report, PAIN (soft pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Relevant concomitant products included medications for high blood pressure and cholesterol.  Treatment information was not provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia oral, Taste disorder
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of taste disorder (bad taste in her mouth 1 day later), oral hypesthesia (lips felt jittery and numb) and oral paresthesia (lips felt jittery and numb) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 008C21A) for COVID-19 immunization. Concurrent medical conditions included abnormal blood pressure and cholesterol. On May 13, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; .5 milliliter. On May 14, 2021, patient experienced taste disorder (bad taste in her mouth 1 day later), oral hypesthesia (lips felt jittery and numb) and oral paresthesia (lips felt jittery and numb). The patient treated with Tylenol (paracetamol), at an unspecified dose and frequency; and rubbing alcohol (isopropanol), at an unspecified dose and frequency, for adverse event. At the time of the report, taste disorder (bad taste in her mouth 1 day later), oral hypesthesia (lips felt jittery and numb) and oral paresthesia (lips felt jittery and numb) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medications included medicine for blood pressure and cholesterol.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired dose/expired vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. No Medical History information was reported. On 05-May-2021 at 3:25 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired dose/expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired dose/expired vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications was reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: ADR Form was received on 17-MAY-2021 Reporter demographics was added. Contact information was added Patient gender was added Race and ethnicity was addeddose1 Information was added Batch no site of vaccination was added date and vaccination was added. On 20-Jul-2021: Follow up was received does not contains any new information.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dysphagia, Eosinophilic oesophagitis, Lichen planopilaris, Vomiting
Clinical narrative: narrowing of the esophagus with the inability to swallow any liquids including water; vomit/mucus and acidic in nature; exacerbation of  pre-existing condition lichen planopilaris; exacerbation of  pre-existing condition lichen planopilaris; exacerbation of  pre-existing eosinophilic esophagitis; This spontaneous case was reported by an other health care professional and describes the occurrence of LICHEN PLANOPILARIS (exacerbation of  pre-existing condition lichen planopilaris), CONDITION AGGRAVATED (exacerbation of  pre-existing condition lichen planopilaris), EOSINOPHILIC OESOPHAGITIS (exacerbation of  pre-existing eosinophilic esophagitis), DYSPHAGIA (narrowing of the esophagus with the inability to swallow any liquids including water) and VOMITING (vomit/mucus and acidic in nature) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-May-2021, the patient experienced LICHEN PLANOPILARIS (exacerbation of  pre-existing condition lichen planopilaris), CONDITION AGGRAVATED (exacerbation of  pre-existing condition lichen planopilaris) and EOSINOPHILIC OESOPHAGITIS (exacerbation of  pre-existing eosinophilic esophagitis). On an unknown date, the patient experienced DYSPHAGIA (narrowing of the esophagus with the inability to swallow any liquids including water) and VOMITING (vomit/mucus and acidic in nature). At the time of the report, LICHEN PLANOPILARIS (exacerbation of  pre-existing condition lichen planopilaris), CONDITION AGGRAVATED (exacerbation of  pre-existing condition lichen planopilaris), DYSPHAGIA (narrowing of the esophagus with the inability to swallow any liquids including water) and VOMITING (vomit/mucus and acidic in nature) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided by the reporter no treatment information reported by the reporter
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient received the expired vaccine thet has passed 30 days window period of refrigeration; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received the expired vaccine thet has passed 30 days window period of refrigeration) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received the expired vaccine thet has passed 30 days window period of refrigeration). On 14-May-2021, EXPIRED PRODUCT ADMINISTERED (The patient received the expired vaccine thet has passed 30 days window period of refrigeration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: mild soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (mild soreness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Allergy to antibiotic (Tetracycline). Concomitant products included INSULIN for Diabetes mellitus.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-1021, the patient experienced PAIN (mild soreness). At the time of the report, PAIN (mild soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.   This case was linked to MOD-2021-059515, MOD-2021-059515 (Patient Link).